Trials

Trials and primary studies

Every primary study the non-Cochrane dental caries reviews include, resolved to one record per study so a trial included by several reviews is counted once. Most are randomized trials; aetiology and diagnostic reviews also include observational and accuracy studies.

Primary studies
5,083
2,113 PMID · 1,332 DOI · 1,638 author and year
In two or more reviews
277
overlap between reviews
Trial PICO extracted
0
extraction not run yet
Per-trial results
0
extraction not run yet
Limit the list

8 studies, most shared first

StudyYearReviewsOutcome linksTrial PICO
Saliva changes in Parkinson’s disease patients after injection of Botulinum neurotoxin type A
Tiigimae-Saar 2018 · Tiigimäe-Saar Janne, Tamme Tiia, et al. · Neurological Sciences
DOI:10.1007/s10072-018-3279-4
20182none statednot extracted yet
Drooling in Parkinson’s disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins
Narayanaswami 2016 · Narayanaswami Pushpa, Geisbush Thomas, et al. · Parkinsonism & Related Disorders
DOI:10.1016/j.parkreldis.2016.07.001
20161none statednot extracted yet
Poster Presentations
Narayanaswami 2015 · Movement Disorders
DOI:10.1002/mds.26295
20151none statednot extracted yet
Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double‐blind trial
Chinnapongse 2012 · Chinnapongse Robert, Gullo Kristen, et al. · Movement Disorders
DOI:10.1002/mds.23929
20111none statednot extracted yet
Long-lasting benefits of botulinum toxin type B in Parkinson’s disease-related drooling
Lagalla 2009 · Lagalla Giovanni, Millevolte Marzia, et al. · Journal of Neurology
DOI:10.1007/s00415-009-0085-1
20091none statednot extracted yet
Botulinum toxin type A for drooling in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study
Lagalla 2006 · Lagalla Giovanni, Millevolte Marzia, et al. · Movement Disorders
DOI:10.1002/mds.20793
20061none statednot extracted yet
A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease
Ondo 2004 · Ondo William G., Hunter Christine, et al. · Neurology
DOI:10.1212/01.wnl.0000101713.81253.4c
20041none statednot extracted yet
Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism
Mancini 2003 · Mancini Francesca, Zangaglia Roberta, et al. · Movement Disorders
DOI:10.1002/mds.10420
20031none statednot extracted yet